Metabolic syndrome in polycystic ovary syndrome

a systematic review, meta-analysis and meta-regression

S. S. Lim, N. S. Kakoly, J. W.J. Tan, G. Fitzgerald, M. Bahri Khomami, A. E. Joham, S. D. Cooray, M. L. Misso, R. J. Norman, C. L. Harrison, S. Ranasinha, H. J. Teede, L. J. Moran

Research output: Contribution to journalReview ArticleResearchpeer-review

13 Citations (Scopus)

Abstract

Introduction: Women with polycystic ovary syndrome (PCOS) have increased risk of metabolic syndrome. The relative contribution of clinical, demographic or biochemical factors to metabolic syndrome in PCOS is not known. A literature search was conducted in MEDLINE, CINAHL, EMBASE and clinical trial registries. Of 4530 studies reviewed, 59 were included in the systematic review and 27 in the meta-analysis and meta-regression. In good and fair quality studies, women with PCOS had an overall increased prevalence of metabolic syndrome (odds ratio, OR 3.35, 95% confidence interval, CI 2.44, 4.59). Increased prevalence of metabolic syndrome occurred in overweight or obese women with PCOS (OR 1.88, 95% 1.16, 3.04) but not in lean women (OR 1.45, 95% CI 0.35, 6.12). In meta-regression analyses, the markers of metabolic syndrome diagnostic criteria (waist circumference, high-density lipoprotein cholesterol, triglyceride, blood pressure), BMI, glucose tolerance (2-hr oral glucose tolerance test) and surrogate markers of insulin resistance (HOMA-IR) but not markers of reproductive dysfunction (sex hormone binding globulin, testosterone, PCOS phenotypes) contributed significantly to the heterogeneity in the prevalence of metabolic syndrome. Women with PCOS have increased risk of metabolic syndrome which was associated with obesity and metabolic features but not with indices of hyperandrogenism.

Original languageEnglish
Pages (from-to)339-352
Number of pages14
JournalObesity Reviews
Volume20
Issue number2
DOIs
Publication statusPublished - Feb 2019

Keywords

  • meta-analysis
  • meta-regression
  • metabolic syndrome
  • polycystic ovary syndrome systematic review

Cite this

Lim, S. S. ; Kakoly, N. S. ; Tan, J. W.J. ; Fitzgerald, G. ; Bahri Khomami, M. ; Joham, A. E. ; Cooray, S. D. ; Misso, M. L. ; Norman, R. J. ; Harrison, C. L. ; Ranasinha, S. ; Teede, H. J. ; Moran, L. J. / Metabolic syndrome in polycystic ovary syndrome : a systematic review, meta-analysis and meta-regression. In: Obesity Reviews. 2019 ; Vol. 20, No. 2. pp. 339-352.
@article{9271a2a3f96f4d7a97ee58dacb6ce10e,
title = "Metabolic syndrome in polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression",
abstract = "Introduction: Women with polycystic ovary syndrome (PCOS) have increased risk of metabolic syndrome. The relative contribution of clinical, demographic or biochemical factors to metabolic syndrome in PCOS is not known. A literature search was conducted in MEDLINE, CINAHL, EMBASE and clinical trial registries. Of 4530 studies reviewed, 59 were included in the systematic review and 27 in the meta-analysis and meta-regression. In good and fair quality studies, women with PCOS had an overall increased prevalence of metabolic syndrome (odds ratio, OR 3.35, 95{\%} confidence interval, CI 2.44, 4.59). Increased prevalence of metabolic syndrome occurred in overweight or obese women with PCOS (OR 1.88, 95{\%} 1.16, 3.04) but not in lean women (OR 1.45, 95{\%} CI 0.35, 6.12). In meta-regression analyses, the markers of metabolic syndrome diagnostic criteria (waist circumference, high-density lipoprotein cholesterol, triglyceride, blood pressure), BMI, glucose tolerance (2-hr oral glucose tolerance test) and surrogate markers of insulin resistance (HOMA-IR) but not markers of reproductive dysfunction (sex hormone binding globulin, testosterone, PCOS phenotypes) contributed significantly to the heterogeneity in the prevalence of metabolic syndrome. Women with PCOS have increased risk of metabolic syndrome which was associated with obesity and metabolic features but not with indices of hyperandrogenism.",
keywords = "meta-analysis, meta-regression, metabolic syndrome, polycystic ovary syndrome systematic review",
author = "Lim, {S. S.} and Kakoly, {N. S.} and Tan, {J. W.J.} and G. Fitzgerald and {Bahri Khomami}, M. and Joham, {A. E.} and Cooray, {S. D.} and Misso, {M. L.} and Norman, {R. J.} and Harrison, {C. L.} and S. Ranasinha and Teede, {H. J.} and Moran, {L. J.}",
year = "2019",
month = "2",
doi = "10.1111/obr.12762",
language = "English",
volume = "20",
pages = "339--352",
journal = "Obesity Reviews",
issn = "1467-7881",
publisher = "Wiley-Blackwell",
number = "2",

}

Metabolic syndrome in polycystic ovary syndrome : a systematic review, meta-analysis and meta-regression. / Lim, S. S.; Kakoly, N. S.; Tan, J. W.J.; Fitzgerald, G.; Bahri Khomami, M.; Joham, A. E.; Cooray, S. D.; Misso, M. L.; Norman, R. J.; Harrison, C. L.; Ranasinha, S.; Teede, H. J.; Moran, L. J.

In: Obesity Reviews, Vol. 20, No. 2, 02.2019, p. 339-352.

Research output: Contribution to journalReview ArticleResearchpeer-review

TY - JOUR

T1 - Metabolic syndrome in polycystic ovary syndrome

T2 - a systematic review, meta-analysis and meta-regression

AU - Lim, S. S.

AU - Kakoly, N. S.

AU - Tan, J. W.J.

AU - Fitzgerald, G.

AU - Bahri Khomami, M.

AU - Joham, A. E.

AU - Cooray, S. D.

AU - Misso, M. L.

AU - Norman, R. J.

AU - Harrison, C. L.

AU - Ranasinha, S.

AU - Teede, H. J.

AU - Moran, L. J.

PY - 2019/2

Y1 - 2019/2

N2 - Introduction: Women with polycystic ovary syndrome (PCOS) have increased risk of metabolic syndrome. The relative contribution of clinical, demographic or biochemical factors to metabolic syndrome in PCOS is not known. A literature search was conducted in MEDLINE, CINAHL, EMBASE and clinical trial registries. Of 4530 studies reviewed, 59 were included in the systematic review and 27 in the meta-analysis and meta-regression. In good and fair quality studies, women with PCOS had an overall increased prevalence of metabolic syndrome (odds ratio, OR 3.35, 95% confidence interval, CI 2.44, 4.59). Increased prevalence of metabolic syndrome occurred in overweight or obese women with PCOS (OR 1.88, 95% 1.16, 3.04) but not in lean women (OR 1.45, 95% CI 0.35, 6.12). In meta-regression analyses, the markers of metabolic syndrome diagnostic criteria (waist circumference, high-density lipoprotein cholesterol, triglyceride, blood pressure), BMI, glucose tolerance (2-hr oral glucose tolerance test) and surrogate markers of insulin resistance (HOMA-IR) but not markers of reproductive dysfunction (sex hormone binding globulin, testosterone, PCOS phenotypes) contributed significantly to the heterogeneity in the prevalence of metabolic syndrome. Women with PCOS have increased risk of metabolic syndrome which was associated with obesity and metabolic features but not with indices of hyperandrogenism.

AB - Introduction: Women with polycystic ovary syndrome (PCOS) have increased risk of metabolic syndrome. The relative contribution of clinical, demographic or biochemical factors to metabolic syndrome in PCOS is not known. A literature search was conducted in MEDLINE, CINAHL, EMBASE and clinical trial registries. Of 4530 studies reviewed, 59 were included in the systematic review and 27 in the meta-analysis and meta-regression. In good and fair quality studies, women with PCOS had an overall increased prevalence of metabolic syndrome (odds ratio, OR 3.35, 95% confidence interval, CI 2.44, 4.59). Increased prevalence of metabolic syndrome occurred in overweight or obese women with PCOS (OR 1.88, 95% 1.16, 3.04) but not in lean women (OR 1.45, 95% CI 0.35, 6.12). In meta-regression analyses, the markers of metabolic syndrome diagnostic criteria (waist circumference, high-density lipoprotein cholesterol, triglyceride, blood pressure), BMI, glucose tolerance (2-hr oral glucose tolerance test) and surrogate markers of insulin resistance (HOMA-IR) but not markers of reproductive dysfunction (sex hormone binding globulin, testosterone, PCOS phenotypes) contributed significantly to the heterogeneity in the prevalence of metabolic syndrome. Women with PCOS have increased risk of metabolic syndrome which was associated with obesity and metabolic features but not with indices of hyperandrogenism.

KW - meta-analysis

KW - meta-regression

KW - metabolic syndrome

KW - polycystic ovary syndrome systematic review

UR - http://www.scopus.com/inward/record.url?scp=85055271216&partnerID=8YFLogxK

U2 - 10.1111/obr.12762

DO - 10.1111/obr.12762

M3 - Review Article

VL - 20

SP - 339

EP - 352

JO - Obesity Reviews

JF - Obesity Reviews

SN - 1467-7881

IS - 2

ER -